These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone. Neu HC; Chin NX Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):644-50. PubMed ID: 2506029 [TBL] [Abstract][Full Text] [Related]
8. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults. Salmon SA; Watts JL Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648 [TBL] [Abstract][Full Text] [Related]
9. [On the effect of hexetidine in vitro]. Linzenmeier G Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760 [No Abstract] [Full Text] [Related]
10. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates. Skar AG; Midtvedt T; Dahl O NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580 [TBL] [Abstract][Full Text] [Related]
11. Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro. Casero RA; Klayman DL; Childs GE; Scovill JP; Desjardins RE Antimicrob Agents Chemother; 1980 Aug; 18(2):317-22. PubMed ID: 7447409 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins. Neu HC; Labthavikul P Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375 [TBL] [Abstract][Full Text] [Related]
13. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830). Jones RN; Barry AL Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422 [TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study]. Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442 [TBL] [Abstract][Full Text] [Related]
15. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae. Verbist L; Verhaegen J Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics. Chin NX; Gu JW; Fang W; Neu HC Diagn Microbiol Infect Dis; 1992; 15(4):331-7. PubMed ID: 1611848 [TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of a new quinolone, AM-1091. Neu HC; Novelli A; Chin NX Antimicrob Agents Chemother; 1989 Jul; 33(7):1036-41. PubMed ID: 2675753 [TBL] [Abstract][Full Text] [Related]
18. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria]. Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142 [TBL] [Abstract][Full Text] [Related]
20. Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model. Shipman C; Smith SH; Drach JC; Klayman DL Antiviral Res; 1986 Jul; 6(4):197-222. PubMed ID: 3017201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]